Reversal of Atrial Substrate to Prevent Atrial Fibrillation Cohort Study
Atrial Fibrillation, Paroxysmal or PersistentAtrial fibrillation (AF) is a major health problem, with a prevalence of 0.4-1% of the population. It results in high healthcare costs and significant morbidity, especially for patients with severe symptoms. The RASTA-AF randomized control trial (RCT) is designed to answer the following question: does vigorous treatment of AF with aggressive risk factor management plus catheter ablation reduce AF-related outcomes as compared to catheter ablation plus usual care in patients with symptomatic AF and risk factors that promote AF.
This study is a multicenter, prospective cohort study that will enrol patients who decline participation in the RASTA-AF RCT but agree to be followed in a registry. The objective of RASTA-Cohort is to determine whether patients who decline participation in the RASTA-AF RCT have different clinical characteristics and quality of life than patients who accept participation in the study, and whether they suffer from worse AF-related outcomes than patients in the RCT.
null
Participation Requirements
-
Sex:
ALL -
Eligible Ages:
18 and up
Participation Criteria
Inclusion Criteria:
* symptomatic AF (CCS-SAF ≥2),
* paroxysmal or persistent atrial fibrillation despite rate control, desiring catheter ablation and either: i) BMI ≥ 30 or, ii) at least two of the following: BMI\>27, BP\>140/90 mmHg or history of hypertension, Diabetes, Heart failure (prior heart failure admission or LVEF\<40%), Age ≥ 65 years, Prior stroke/TIA, Current smoker, Excessive alcohol use {For women: 10 or more drinks/week, more than 2 drinks a day (most days). For men: 15 or more drinks/week, more than 3 drinks a day (most days)}, and iii) declined or were not approached for participation in the main study. Eligible patients must have received catheter ablation for AF during the same timeline of the RASTA-AF Mian Study (November 1st, 2019 to December 31st, 2025).
Exclusion Criteria:
* permanent AF (AF lasting \> 3 years),
* prior catheter ablation for AF
* New York Heart Association Class IV heart failure
* participation in a cardiac rehabilitation program within the last year,
* currently performing exercise training \>150 minutes/week of moderate to vigorous physical activity,
* unable to exercise,
* unable to give informed consent,
* other noncardiovascular medical condition making 1 year survival unlikely
* less than 18 years of age
Study Location
QEIIHSC
QEIIHSCHalifax, Nova Scotia
Canada
Contact Study Team
Foothills Hospital
Foothills HospitalCalgary, Alberta
Canada
Contact Study Team
Jennifer McKeage
Sunnybrook Hospital
Sunnybrook HospitalToronto, Ontario
Canada
Contact Study Team
Ambreen Syeda
London Health Sciences Centre
London Health Sciences CentreLondon, Ontario
Canada
Contact Study Team
Keza Motlana
Regina General Hospital
Regina General HospitalRegina, Saskatchewan
Canada
Contact Study Team
Maria Gagarinova
University of Ottawa Heart Institute
University of Ottawa Heart InstituteOttawa, Ontario
Canada
Contact Study Team
Tammy Knight
Montreal Heart Institute
Montreal Heart InstituteMontreal, Quebec
Canada
Contact Study Team
Caroline Girard
- Study Sponsored By
- Nova Scotia Health Authority
- Participants Required
- More Information
- Study ID:
NCT06249269